MESSAGE
ご挨拶
With aspiration and honesty, TOKIWA-Bio pursue and discover businesses that are useful to society.
MESSAGE
COMPANY
ABOUT US
COMPANY
ABOUT US
Undertake the Future on “Advanced Therapies” !
Gene cell therapy and regenerative medicine for practical use are actively R&Ding at universities and pharmaceutical companies as new therapies. Tokiwa-Bio Inc., developed a safe and stable gene expression technology with new approaches by transferring technology from AIST. Stealth RNA Vector(SRV) enable highly efficient and stable expression of multiple genes and large genes in the cytoplasm, which have been researched and developed as technologies necessary for highly safe gene cell therapy and regenerative medicine.
PHILOSOPHY
企業理念
TOKIWA-Bio, is striving for curing people suffering genetic diseases in the world.
PHILOSOPHY
COMPANY PROFILE
TOKIWA-Bio, is striving to realize gene cell therapy and regenerative medicine with Stealth RNA Vector (SRV).
- striving for curing people suffering genetic diseases in the world -
PROFILE
HISTORY
沿革
In the cutting-edge medical field, a Japanese venture company - TOKIWA-Bio, sets goal to contribute to the world!
HISTORY